Can a New Scoring System Predict Hemodynamically Significant PDA Diagnosis and Treatment Requirement for Extremely Preterm Newborns Earlier
试验速览
- 阶段
- 不适用
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Number of Participants with Patent Ductus Arteriosus
研究概览
简要总结
Patent ductus arteriosus (PDA) is an important morbidity of that the diagnosis and treatment is controversy in premature infants. A number of scoring systems have been developed, including the findings of echocardiography on the diagnosis and treatment of PDA. This study aimed to develop a new clinical scoring system that will enable the rapid, standard and noninvasive evaluation of hemodynamically significant PDA earlier, without relying on echocardiographic findings in premature babies with extremely low birth weight, and to determine the role of this scoring system in early diagnosis and treatment.
详细描述
This study aimed to develop a new clinical scoring system that will enable the rapid, standard and noninvasive evaluation of hemodynamically significant PDA earlier, without relying on echocardiographic findings in premature babies with extremely low birth weight, and to determine the role of this scoring system in early diagnosis and treatment.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- — 至 15 Days（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •informed consent obtained from parents
- •extremely preterm infants
- •infants born before 28 gestational week
排除标准
- •lack of informed consent
- •chromosomal abnormality
- •cardiovascular abnormality
结局指标
主要结局
Number of Participants with Patent Ductus Arteriosus
时间窗: 7 days
number of participants who diagnosed for hemodynamically significant PDA and had an elevated score of the newly developed system by us.
次要结局
未报告次要终点
研究者
Merih Cetinkaya
Neonatologist
Kanuni Sultan Suleyman Training and Research Hospital